Author Archives: admin

FDA CDER Director on Benlysta for lupus and adaptive clinical trials.

July 27, 2011- Janet Woodcock, MD, Director of the FDAs new drug division, CDER, discusses with Steven Greer,

Posted in - Biotech, - Pharma, FDA, Rheumatology | Leave a comment

The Who’s Teen Cancer Lounge at Sloan Kettering opens

March 18, 2016- by Steven E. Greer MD The Memorial Sloan Kettering Cancer Center held a press day for its new teen lounge

Posted in Memorial Sloan-Kettering, Oncology | Leave a comment

COVID mRNA gene therapies never worked and are now clearly harmful

November 5, 2021- by Steven E. Greer, MD In the most prestigious journal in all of science, Science magazine posted this article. The authors studied vaccine efficacy over time in VA patients. The effectiveness at preventing COVID infections fell to … Continue reading

Posted in - Biotech, - Opinion, - Pharma, - Policy | Leave a comment

Early stoppage of clinical trials

April 16, 2009– Dr. Guyatt explained in a previous post why early stoppage of clinical trials results

Posted in Cardiac surgery, FDA, McMaster University | Leave a comment

Gordon Guyatt, MD: on the problem of early stoppage of clinical trials

January 7, 2009- The ARBITER 6-HALTS study investigating Zetia and Niaspan was stopped

Posted in Cardiology, FDA, McMaster University | Leave a comment

Bobby Kennedy Jr. explains how Tony Fauci killed 300,000 AIDS patients

January 12, 2022- RFK Jr. explains how Tony Fauci killed 300,000 AIDS patients by refusing to approve

Posted in - Opinion, Congress, FDA, Infectious disease, NIH | Leave a comment

Current surgical weight loss therapies

January 24, 2014- Interviewed by Steven E. Greer, MD Erik Dutson, MD, weight loss surgeon at UCLA, explains why his medical center does not implant the Lap-Band,

Posted in - Medical Devices, Bariatric surgery, General surgery, UCLA | Leave a comment

Steven E. Greer, MD on OANN discussing virus therapies

April 16, 2020

Posted in - Biotech, - Generics, - Opinion, - Pharma, CDC, CMS, Congress, Emergency medicine, FDA, Geriatrics, Infectious disease, Internal Medicine, NIH, Pediatrics, Primary care medicine, Pulmonology, VA | Leave a comment

WLIR’s Frank Morano interviews Steven E. Greer, MD about The Wuhan virus and herd immunity: 8-3-2020

August 3, 2020

Posted in - Policy | Leave a comment

The Medicaid Roundtable

Part 1: Medicaid primer Part 2: State spending on Medicaid

Posted in CMS | Leave a comment

Rudy Giuliani interviews Steven E. Greer, MD on WABC radio- May 6, 2020

May 6, 2020

Posted in - Opinion, - Policy, CDC, CMS, Congress, Emergency medicine, FDA, Infectious disease, NIH | Leave a comment

The Deans of Johns Hopkins and Miami discuss ACO’s

February 28, 2011- By Steven E Greer, MD Dean Miller of Johns Hopkins and Dean Goldschmidt of Miami discuss accountable care organizations,

Posted in - Policy, CMS, Johns Hopkins | Leave a comment

Is Vitamin-D deficiency overdiagnosed?

November 8, 2016- Interviewed by Steven E. Greer, MD We interviewed JoAnn E. Manson, MD, DrPH, Chief, Division of Preventive Medicine,  Brigham

Posted in - NEJM, - Policy, CDC, Diabetes and endocrinology, FDA, Harvard, Primary care medicine | Leave a comment

Alex Berenson sues Biden, the Pfizer CEO, Scott Gottlieb, and others

May 15, 2023-

Posted in - Pharma, - Policy | Leave a comment

CRISPR is the biggest threat to mankind

June 23, 2021- by Steven E. Greer Today, I received my media embargo copy of a New England Journal of Medicine article on genetic engineering

Posted in - Biotech, - Opinion, - Policy, Congress, FDA, Genetics, NIH | Leave a comment

Ivermectin works as an antiviral against SARS-CoV-2 (COVID-19)

Update September 4, 2022- A new peer-reviewed study found that regular use of ivermectin reduced the risk of dying from COVID-19 by 92%.

Posted in - Biotech, - Generics, - Pharma, FDA, Infectious disease | Leave a comment

Did the COVID vaccines change the human genome?

May 11, 2023- by Steven E. Greer, MD I was the first person on any large media platform to warn that the COVID vaccines would be hard to sell because they worked by altering our genes. I said this on … Continue reading

Posted in - Biotech, - Opinion, - Pharma, - Policy, Cardiology, CDC, FDA, Infectious disease, Internal Medicine, Neurology, NIH, Oncology | Leave a comment

Joe Piscopo interviews Steven E. Greer, MD: 5-22-2020

May 22, 2020

Posted in - Biotech, - Generics, - Opinion, - Pharma, - Policy, Emergency medicine, Infectious disease, Pulmonology | Leave a comment

WABC radio morning show Bernie & Sid interviews Steven E. Greer, MD: May 21, 2020

May 21, 2020- by Steven E. Greer, MD In this segment,

Posted in - Opinion, - Pharma, - Policy, Emergency medicine, Infectious disease, Internal Medicine, Pulmonology | Leave a comment

The Joe Piscopo show interviews Steven E. Greer, MD- May 12, 2020

May 12, 2020- by Steven E. Greer In this episode, I discuss:

Posted in - Opinion, - Policy | Leave a comment